Category: 1

1, 3, administration, agency, analysis, analytics, Biden, business, Business Analysis, cbd, compliance, controlled substances act, dea, Department of Health and Human Services, Federal, government, HHS, I, III, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, reclassify, recommend, recommendation, recreational, regulation, regulations, regulatory, schedule, state

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary […]

1, 3, administration, analysis, analytics, Biden, business, Business Analysis, cannabis, dea, Federal, government, HHS, I, III, law, legal, legalization, legalize, legislation, marijuana, market, medical, medicine, recreational, regulation, regulatory, rescheduling, schedule, scheduling, state

HHS Recommends DEA Reschedule Cannabis to Schedule III

HHS Recommends DEA Reschedule Cannabis to Schedule III

Massively promising news for the cannabis industry today that many are calling historic: the Department of Health and Human Services (HHS) has […]

1, Act, ADOR, ALTA, analysis, analytics, bank, banking, blockchain, BSA, business, Business Analysis, cannabis, cash, compliance, compliant, CRB, crypto, CSA, Dama, digital, DOJ, economic, economy, Federal, finance, financial, government, growing, industry, institution, laundering, law, legal, legalization, legalize, legislation, lending, license, loan, marijuana, market, MLCA, money, NaturePay, Partners Credit Union, product, recreational, regulation, regulations, regulatory, retail, risk, Safe Harbor, Safe Harbor Private Banking, schedule, state, trend

Current Trends in Banking for Cannabis-Related Businesses

Current Trends in Banking for Cannabis-Related Businesses

Cannabis is still federally illegal and is included on Schedule 1 of the Controlled Substances Act (CSA), along with such other substances […]

1, 19, 2020, 2021, 4, adult use, analysis, analytics, ballot, Biden, business, Business Analysis, CANADA, canadian, cannabis, cbd, commission, compliance, consumer, Coronavirus, court, COVID, COVID-19, cultivation, Denmark, deschedule, EC, economy, election, EU, Euro, europe, European, export, extraction, Federal, German, Germany, global, globe, government, growing, Holland, I, import, industry, initative, international, IV, law, legal, legalization, legalize, legislation, license, Luxembourg, marijuana, market, measure, medical, medicine, pandemic, policies, policy, Portugal, product, Quality, Recommendations, recreational, referendum, regulation, regulations, regulatory, reschedule, rescheduled, retail, safety, schedule, scheduling, spain, state, test, Testing, thc, UN, union, United Nations, vote, WHO, world, World Health Organization, worldwide

The 2020 Global Cannabis Regulatory Roundup

The 2020 Global Cannabis Regulatory Roundup

As a strange year heads to a final, painful finish, there have been some major (and some less so) changes afoot in […]

1, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

1, administration, analysis, analytics, assistance, business, Business Analysis, california, cannabis, cbd, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, Cultivation & Growing, designate, designation, disaster, Dispensaries & Retail, dispensary, Economic Injury Disaster Loans, Edibles & Processing, EIDL, emergency, Emergency Cannabis Small Business Health and Safety Act, essential, extraction, Federal, financial, government, growing, illegal, industry, lab, laboratories, Laboratories & Analytics, laboratory, law, legal, legalization, legalize, legislation, license, loan, marijuana, market, medical, medicine, microloan, nonessential, Operations, paycheck protection program, PPP, product, provider, Quality, recreational, regulation, regulations, regulatory, relief, retail, safety, SBA, schedule I, service, small, small business administration, state, test, Testing, thc

Emergency Cannabis Small Business Health and Safety Act – A Legislative Update

Emergency Cannabis Small Business Health and Safety Act – A Legislative Update

On Thursday April 23, 2020, Representatives Earl Blumenauer (D-OR) and Ed Perlmutter (D-CO) introduced the “Emergency Cannabis Small Business Health and Safety […]